Last Updated on May 21, 2023 by The Health Master
As the government is moving to impose a price ceiling on essential drugs / medicines, the pharmaceutical industry is looking for an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit.
Citing people aware of the developments, the newspaper reported that the industry lobby met government officials to request an exemption from the implementation of trade margin rationalisation (TMR) for formulations that cost less than Rs 10 per unit as well.
The industry and the government are on the same page on TMR, however, the industry wants it to be implemented in a phased manner.
The Indian Pharmaceutical Alliance (IPA) represents the country’s biggest drug manufacturing companies.
IPA, along with other lobby groups in their suggestions to the government asked for exemption from price ceiling regulations for low-priced formulations, the report said.
With support from the Indian Drug Manufacturers’ Association and the Organisation of Pharmaceutical Producers of India, the alliance was joined also joined by Karnataka Drugs & Pharmaceutical Manufacturers, among other bodies.
The National Pharmaceutical Pricing Authority (NPPA) is empowered to impose price ceilings on essential drugs / medicines under Schedule I of the Drugs (Price Control) order 2013.
The government resumed the discussions regarding TMR on drugs and medical devices with industry stakeholders on May 16.
To facilitate meaningful dialogue, the Department of Pharmaceuticals and the NPPA organised a meeting and invited members of Pharma associations and medical device manufacturers to understand their concerns and seek their suggestions.
One more arrest in Spurious Pharma Raw Material case
NPPA fixed retail price of 15 formulations: May 2023
Revising DT limit for Soft Gelatin Capsules: Pharma Industry seek solutions
Drug alert: 36 out of 895 samples declared as NSQ in April 2023
Revising DT limit for Soft Gelatin Capsules: Pharma Industry seek solutions
USFDA issues Form 483 with zero observations to Pharma MSMEs: Gujarat
Govt to amend New Drugs and Clinical Trials Rules 2019 (NDCTR)
USFDA completes inspection of Hikal Pharma with zero observation
Govt amends Para 5 and Para 18 of DPCO 2013
Surprise Inspection of 35 Medical Store: 8 Suspended, One Sealed
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
